VRAX
VRAX
NASDAQ · Health Care

Virax Biolabs Group Ltd

$0.23
+0.00 (+2.03%)
As of Feb 8, 2:35 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 514.8K 538.6K 459.7K
Net Income 74.6K 66.4K 71.8K
EPS
Profit Margin 14.5% 12.3% 15.6%
Rev Growth +21.9% -4.1% +16.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 378.4K 385.3K 374.1K
Total Equity 1.00M 916.7K 903.3K
D/E Ratio 0.38 0.42 0.41
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 106.1K 122.1K 91.8K
Free Cash Flow 64.8K 82.7K 52.1K